Antidepressants for children and teens
Learn why antidepressants have warnings about suicidal thinking in children and teens, what to do before your child starts taking an antidepressant, and the warning signs of a potential problem.
By Mayo Clinic Staff
Antidepressant drugs are often an effective way to treat depression and anxiety in children and teenagers. However, antidepressant use in children and teens must be monitored carefully, as rarely there can be severe side effects.
Antidepressants carry a Food and Drug Administration (FDA) black box warning about a risk of increased suicidal thinking and behavior in some individuals under the age of 25.
Although at first you may find the suicide warnings alarming, it's important to get the facts. Find out what the warnings mean and ask about all treatment options. This will help you make an informed decision about your child's health and weigh the benefits and risks of treatment options with your child's doctor.
Why do antidepressants have warnings about suicidal behavior in children?
The FDA reported that an extensive analysis of clinical trials showed that antidepressants may cause or worsen suicidal thinking or behavior in a small number of children and teens. The analysis showed that children and teens taking antidepressants had a small increase in suicidal thoughts, compared with those taking a sugar pill (placebo).
None of the children in any of the studies actually took his or her own life. Still, the FDA considered the findings concerning enough to issue a public health advisory and require manufacturers to label antidepressants with strong warnings about the link to suicidal thinking and behavior in children, adolescents and young adults ages 18 through 24.
However, not all mental health researchers believe these warnings are necessary. Newer research indicates that the benefits of antidepressants may be greater than the risk of suicide. And some research indicates that suicide rates in children decrease when they take antidepressants.
Which antidepressants must have the warnings about suicide?
Although the FDA analysis examined only nine antidepressants, the FDA extended the warning to all prescription antidepressants. This black box warning is the strongest safety warning that the FDA can issue about a prescription drug. The warning is printed in bold type framed in a black border at the top of the paper inserts that come with antidepressants.
How can medication meant to help treat depression and other illnesses lead to suicidal behavior in children?
Because of the risk of suicide from depression, it's difficult to establish a clear causal relationship between antidepressant use and suicide. Researchers speculate about a variety of potential reasons for an increased risk. In some children, antidepressants may also trigger anxiety, agitation, hostility, restlessness or impulsive behavior. These effects may indicate that the child's depression is getting worse or that the child is starting to develop suicidal thoughts.
Should children be treated with antidepressants at all?
The warnings about a possible link between antidepressants and suicidal thoughts do not mean that antidepressants should not be used in children. Nor are the warnings meant to frighten people away from antidepressants. However, the warnings should be taken as a caution to carefully weigh the pros and cons of using antidepressants in children and teenagers against the real risk of suicide as a result of untreated depression.
For many children and teens, antidepressants are an effective way to treat depression, anxiety, obsessive-compulsive disorder or other mental health conditions. If these conditions aren't treated effectively, your child may not be able to lead a satisfying, fulfilled life or do normal, everyday activities.
May 27, 2016
- Moreland CS, et al. Effect of antidepressants on suicide risk in children and adolescents. http://www.uptodate.com/home. Accessed May 5, 2016.
- Cooper WO, et al. Antidepressants and suicide attempts in children. Pediatrics. 2014;133:204.
- Friedman RA. Antidepressants' black-box warning — 10 years later. New England Journal of Medicine. 214;371:1666.
- Revisions to product labeling. U.S. Food and Drug Administration. http://www.fda.gov/downloads/Drugs/DrugSafety/InformationbyDrugClass/UCM173233.pdf. Accessed May 5, 2016.
- FDA: Don't leave childhood depression untreated. U.S. Food and Drug Administration. http://www.fda.gov/forconsumers/consumerupdates/ucm413161.htm. Accessed May 5, 2016.
- Isacsson G, et al. Antidepressant drugs and the risk of suicide in children and adolescents. Pediatric Drugs. 2014;16:115.
- Gibbons RD, et al. Antidepressant treatment and suicide attempts and self-inflicted injury in children and adolescents. Pharmacoepidemiology and Drug Safety. 2015;24:208.
- Bonin L, et al. Overview of treatment for pediatric depression. http://www.uptodate.com/home. Accessed May 6, 2016.
- Leckman JF. The risk and benefits of antidepressants to treat pediatric-onset depression and anxiety disorders: A developmental perspective. Psychotherapy and Psychosomatics. 2013;82:129.
- Gordon MS, et al. Do antidepressants make children and adolescents suicidal? Journal of Paediatrics and Child Health. 214;50:847.
- Croarkin PE (expert opinion). Mayo Clinic, Rochester, Minn. May 13, 2016.
- Antidepressant medications: U.S. Food and Drug Administration-approved indications and dosages for use in pediatric patients. Centers for Medicare and Medicaid Services. https://www.cms.gov/Medicare-Medicaid-Coordination/Fraud-Prevention/Medicaid-Integrity-Education/Pharmacy-Education-Materials/Downloads/ad-pediatric-dosingchart.pdf. Accessed May 11, 2016.
- Cymbalta (prescribing information). Indianapolis, Ind.: Eli Lilly and Company; 2015. https://www.lilly.com/Products/Human/From-Our-History.aspx. Accessed May 11, 2016.
- Symbyax (prescribing information). Indianapolis, Ind.: Eli Lilly and Company; 2015. https://www.lilly.com/Products/Human/From-Our-History.aspx. Accessed May 11, 2016.
- Krieger CA (expert opinion). Mayo Clinic, Rochester, Minn. May 18, 2016.